BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
BioTime (BTX) Closes $31 Million Financing 10/9/2014 9:02:44 AM
LifeMap Sciences Announces Release And Commercial Availability Of Geneanalytics™ 1.0, A Powerful Gene Set Analysis Tool Powered By Genecards®, Lifemap Discovery® And Malacards 10/6/2014 9:09:07 AM
LifeMap Sciences, A Subsidiary Of BioTime (BTX), Announces Release Of Malacards Version 1.06 With Greatly Improved Gene-Disease Associations 10/6/2014 9:02:30 AM
BioTime (BTX) And Subsidiaries To Raise $31 Million Through Sales Of Common Shares 10/6/2014 8:57:17 AM
Michael H. Mulroy And Stephen L. Cartt Joining BioTime (BTX) Board Of Directors 10/6/2014 8:31:06 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation Announces Completion Of Multi-Site Clinical Study Of Lung Cancer Diagnostic By Collaborators At The Wistar Institute 10/3/2014 7:30:26 AM
BioTime (BTX)'s Subsidiary OncoCyte Corporation's CEO Dr. Joseph Wagner To Present At BTIG’s Inaugural “Emerging Technologies In Healthcare Diagnostics” Symposium 9/19/2014 8:28:40 AM
BioTime (BTX) Announces Presentation Of Phase 3 Data At EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 9/19/2014 7:23:10 AM
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Demonstrates The Safety And Efficacy Of Opregen® In Preclinical Animal Studies 9/17/2014 11:02:24 AM
BioTime (BTX)'s Subsidiary OncoCyte Corporation And Abcodia To Collaborate On Breast Cancer Diagnostic Development 9/15/2014 11:00:54 AM
12345678910...